These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20820958)

  • 1. Childhood rhabdomyosarcoma: new insight on biology and treatment.
    Huh WW; Skapek SX
    Curr Oncol Rep; 2010 Nov; 12(6):402-10. PubMed ID: 20820958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
    Ferrari A; Dileo P; Casanova M; Bertulli R; Meazza C; Gandola L; Navarria P; Collini P; Gronchi A; Olmi P; Fossati-Bellani F; Casali PG
    Cancer; 2003 Aug; 98(3):571-80. PubMed ID: 12879475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
    Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
    J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyosarcoma in children - current pathologic and molecular classification.
    Dziuba I; Kurzawa P; Dopierała M; Larque AB; Januszkiewicz-Lewandowska D
    Pol J Pathol; 2018; 69(1):20-32. PubMed ID: 29895123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma.
    Seitz G; Warmann SW; Vokuhl CO; Heitmann H; Treuner C; Leuschner I; Fuchs J
    Pediatr Surg Int; 2007 May; 23(5):431-9. PubMed ID: 17211591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
    J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature.
    Anderson JR; Barr FG; Hawkins DS; Parham DM; Skapek SX; Triche TJ
    J Clin Oncol; 2010 Oct; 28(29):e587-8; author reply e589-90. PubMed ID: 20697086
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosing alveolar rhabdomyosarcoma: morphology must be coupled with fusion confirmation.
    Wexler LH; Ladanyi M
    J Clin Oncol; 2010 May; 28(13):2126-8. PubMed ID: 20351321
    [No Abstract]   [Full Text] [Related]  

  • 9. Is alveolar histotype a prognostic factor in paratesticular rhabdomyosarcoma? The experience of Italian and German Soft Tissue Sarcoma Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Brecht IB; Alaggio R; Cecchetto G; Provenzi M; Koscielniak E; Treuner J; Carli M
    Pediatr Blood Cancer; 2004 Feb; 42(2):134-8. PubMed ID: 14752876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma.
    Harms D
    Curr Top Pathol; 1995; 89():273-96. PubMed ID: 7882714
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
    Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
    J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Strategy for Pediatric Paratesticular Rhabdomyosarcoma Based on Chimeric Gene Assessment.
    Unno R; Mizuno K; Ito Y; Etani T; Okada A; Kawai N; Yasui T; Saitoh S; Hayashi Y
    Urology; 2016 Sep; 95():187-9. PubMed ID: 27017905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of presentation and outcome of ophthalmic rhabdomyosarcoma in Ibadan.
    Fasina O
    Afr J Med Med Sci; 2013 Jun; 42(2):165-9. PubMed ID: 24377202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
    Harms D
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma of the tongue.
    Doval DC; Kannan V; Acharya RS; Mukherjee G; Shenoy AM; Bapsy PP
    Br J Oral Maxillofac Surg; 1994 Jun; 32(3):183-6. PubMed ID: 8068593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible benefits of high-dose chemotherapy as intensive consolidation in patients with high-risk rhabdomyosarcoma who achieve complete remission with conventional chemotherapy.
    Matsubara H; Makimoto A; Higa T; Kawamoto H; Takayama J; Ohira M; Yokoyama R; Beppu Y; Takaue Y
    Pediatr Hematol Oncol; 2003; 20(3):201-10. PubMed ID: 12637216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
    Ruymann FB; Grovas AC
    Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
    Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M
    Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.